April 05, 2017
1 min watch
Save
VIDEO: Speaker highlights importance of diagnosing patients with EPGA and cardiac manifestations
CLEVELAND — At Biologic Therapies VII Summit, W.H. Wilson Tang, MD, in the Department of Cardiovascular Medicine at the Heart and Vascular Institute of the Cleveland Clinic, spoke about patients with eosinophilic granulomatosis polyangiitis (EGPA) and their cardiac manifestations.
Tang said rheumatologists “should look carefully at the heart.” About 50% of deaths in patients with EGPA have cardiac manifestations, so it is important to diagnose and treat these patients, Tang said.